|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of KalVista Pharmaceuticals (NASDAQ: KALV) through any online brokerage.
The latest price target for KalVista Pharmaceuticals (NASDAQ: KALV) was reported by Roth Capital on February 18, 2021. The analyst firm set a price target for 55.00 expecting KALV to rise to within 12 months (a possible 91.37% upside). 6 analyst firms have reported ratings in the last year.
The stock price for KalVista Pharmaceuticals (NASDAQ: KALV) is $28.74 last updated Fri Jun 11 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for KalVista Pharmaceuticals.
There is no upcoming split for KalVista Pharmaceuticals.
KalVista Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.